Evidence map›Paper›PMID 31423752›Full record

ArticleJournal of the International AIDS Society2019

Performance of fracture risk assessment tool in HIV-positive male individuals aged ≥45 years on suppressive antiretroviral therapy.

Mao-Song Tsai, Jun-Yu Zhang, Hsin-Yun Sun, Wen-Chun Liu, Pei-Ying Wu, Chia-Jui Yang, Chien-Ching Hung

Abstract read
In one paragraph

Article in Journal of the International AIDS Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mao-Song TsaiDepartment of Internal Medicine, Far Eastern Memorial Hospital, New Taipei City, Taiwan.
Jun-Yu ZhangCenter of Infection Control, National Taiwan University Hospital, Taipei, Taiwan.
Hsin-Yun SunDepartment of Internal Medicine, National Taiwan University Hospital and National, Taiwan University College of Medicine, Taipei, Taiwan.
Wen-Chun LiuDepartment of Internal Medicine, National Taiwan University Hospital and National, Taiwan University College of Medicine, Taipei, Taiwan.
Pei-Ying WuCenter of Infection Control, National Taiwan University Hospital, Taipei, Taiwan.
Chia-Jui YangDepartment of Internal Medicine, Far Eastern Memorial Hospital, New Taipei City, Taiwan.ORCID 0000-0002-5925-2064
Chien-Ching HungDepartment of Internal Medicine, National Taiwan University Hospital and National, Taiwan University College of Medicine, Taipei, Taiwan.ORCID 0000-0001-7345-0836

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAn age-specific evaluation and management algorithm for reduced bone mineral density (BMD) is suggested for HIV-positive patients without major risk factors. Whether combination of BMD and the Fracture Risk Assessment Tool (FRAX) may detect more individuals for therapeutic interventions remains unclear. We aimed to determine the prevalence of middle-aged or older HIV-positive males fitting the criteria of therapeutic interventions with different approaches.

methodsFrom July 2016 to February 2018, HIV-positive male patients aged ≥45 years receiving suppressive antiretroviral therapy were recruited in a cross-sectional study, at two designated hospitals for HIV care in northern Taiwan. Patients with malignancy, AIDS, pre-existing bone disease or immobilization were excluded. Information on clinical and demographic characteristics, FRAX questionnaire, activity questionnaire, BMD and serum 25(OH)D was obtained. FRAX scores combined with BMD (FRAX/BMD) and without BMD (FRAX) were calculated. The data were analysed on the basis of major risk factors for fragility fracture and age stratification, FRAX score and BMD results respectively.

resultsWe enrolled 330 patients with a mean age of 51.6 years and CD4 610 cells/μL, in whom 98.1% (n = 324) underwent BMD assessment of one site or more. By FRAX, 6.7% (n = 22) reached treatment thresholds (10-year risk of major osteoporotic fracture ≥20% and/or hip fracture ≥3%). The prevalence of osteopenia (-2.5 <T-score <-1) and osteoporosis (T-score ≤-2.5) was 50.3% and 10.8% respectively. Compared with FRAX, FRAX/BMD identified 17.4% (95% CI 12.0% to 22.8%) more individuals who reached treatment thresholds (24.1% vs. 6.7%); even in the low-risk group (without major risks for fragility fracture, 45 to 49 years, n = 129), FRAX/BMD identified 12.6% (95% CI 7.9% to 19.7%) more candidates (12.6% vs. 0%). Patients with BMI<22 kg/m

conclusionsWith FRAX as a screening approach among HIV-positive male patients aged ≥45 years, addition of BMD assessment may detect more candidates for therapeutic management.

Indexed as

AdultAlgorithmsAnti-HIV AgentsBone DensityCross-Sectional StudiesFractures, BoneHip FracturesHIV SeropositivityHumansMaleMiddle AgedOsteoporosisOsteoporotic FracturesPrevalenceRisk FactorsSurveys and QuestionnairesAnti-HIV Agentsageingbone mineral densitycombination antiretroviral therapyosteopeniaosteoporosis

Identifiers

PMID31423752
PMCPMC6698691

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.